Ameritas Investment Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$270K Hold
12,519
0.01% 1132
2025
Q1
$208K Hold
12,519
0.01% 1240
2024
Q4
$230K Buy
12,519
+795
+7% +$14.6K 0.01% 1241
2024
Q3
$180K Hold
11,724
0.01% 1390
2024
Q2
$191K Sell
11,724
-820
-7% -$13.3K 0.01% 1299
2024
Q1
$232K Hold
12,544
0.01% 1190
2023
Q4
$393K Buy
12,544
+504
+4% +$15.8K 0.01% 892
2023
Q3
$251K Buy
12,040
+2,033
+20% +$42.4K 0.01% 1044
2023
Q2
$240K Buy
10,007
+623
+7% +$14.9K 0.01% 1025
2023
Q1
$177K Hold
9,384
0.01% 1175
2022
Q4
$179K Hold
9,384
0.01% 1209
2022
Q3
$153K Hold
9,384
0.01% 1205
2022
Q2
$132K Hold
9,384
0.01% 1310
2022
Q1
$227K Hold
9,384
0.01% 1108
2021
Q4
$219K Hold
9,384
0.01% 1170
2021
Q3
$156K Hold
9,384
0.01% 1394
2021
Q2
$229K Buy
+9,384
New +$229K 0.01% 1143
2020
Q2
Sell
-9,809
Closed -$414K 3056
2020
Q1
$414K Buy
9,809
+134
+1% +$5.66K 0.02% 679
2019
Q4
$414K Buy
9,675
+738
+8% +$31.6K 0.02% 797
2019
Q3
$322K Hold
8,937
0.01% 857
2019
Q2
$239K Sell
8,937
-403
-4% -$10.8K 0.01% 975
2019
Q1
$251K Buy
9,340
+1,216
+15% +$32.7K 0.01% 935
2018
Q4
$131K Hold
8,124
0.01% 1205
2018
Q3
$169K Hold
8,124
0.01% 1200
2018
Q2
$124K Buy
+8,124
New +$124K 0.01% 1385
2016
Q1
Sell
-6,151
Closed -$219K 1172
2015
Q4
$219K Hold
6,151
0.01% 899
2015
Q3
$203K Hold
6,151
0.01% 921
2015
Q2
$258K Sell
6,151
-909
-13% -$38.1K 0.02% 873
2015
Q1
$230K Hold
7,060
0.02% 953
2014
Q4
$224K Buy
+7,060
New +$224K 0.02% 939